BIOGEN INC. (BIIB) Net margin 2016–2025
BIOGEN INC. (BIIB) net profit margin by fiscal year — reported net income divided by reported revenue.
13.1%FY2025 · since FY2016: 32.3% → 13.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 13.1% | -3.8 pp |
| FY2024 | 16.9% | +5.1 pp |
| FY2023 | 11.8% | -18.1 pp |
| FY2022 | 30.0% | +15.8 pp |
| FY2021 | 14.2% | -15.6 pp |
| FY2020 | 29.8% | -11.2 pp |
| FY2019 | 41.0% | +8.0 pp |
| FY2018 | 32.9% | +12.2 pp |
| FY2017 | 20.7% | -11.7 pp |
| FY2016 | 32.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice